4 Aug 2026Open access
Pharmacokinetics of abacavir and lamivudine in infants living with HIV with and without rifampicin co-treatmentPublisher siteJournal of Antimicrobial Chemotherapy, HIV/AIDS drug development and treatment
UniversitiesNatasha Namuziya
Active, last published 2026
In hiv/aids drug development and treatment
Natasha
Namuziya
Scholar“Research focused on HIV/AIDS drug development and treatment and adjacent fields.”
Claim Your Profile3
H-index
26
Citations
Natasha has not officially claimed their profile. If you are Natasha, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
atasha Namuziya is a researcher working on HIV/AIDS drug development and treatment. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Natasha's work has been cited 26 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
HIV/AIDS drug development and treatment×5HIV/AIDS Research and Interventions×4Tuberculosis Research and Epidemiology×4Pneumocystis jirovecii pneumonia detection and treatment×3Pneumonia and Respiratory Infections×2
04 · Where I am
Affiliations
Affiliation details will appear once this profile is updated.
Research themes (UN SDGs)
05 · Selected work
Recent publications
5 works1 Jul 2026Open access
Empirical treatment with valganciclovir in infants living with HIV and hospitalised with severe pneumonia in Africa: a multicentre, open-label, factorial, randomised, controlled, superiority trialPublisher siteThe Lancet, Cytomegalovirus and herpesvirus research
1 May 2026Open access
Validation of treatment decision algorithms for childhood tuberculosis at district healthcare levels in Mozambique and Zambia: the Decide TB cluster-randomised pragmatic trial – a study protocolPublisher siteBMJ Open, Tuberculosis Research and Epidemiology
1 Apr 2026Open access
Pharmacokinetics and pharmacodynamics of valganciclovir in infants with severe HIV-associated pneumonia in Africa: a sub-study of the EMPIRICAL randomised controlled trialPublisher siteEClinicalMedicine, HIV/AIDS drug development and treatment
5 Feb 2026Open access
Genomic analysis of <i>Klebsiella pneumoniae</i> causing community-acquired respiratory deaths among Zambian infants and children using targeted RNA-probe hybridization-capture metagenomicsPublisher sitebioRxiv (Cold Spring Harbor Laboratory), Antibiotic Resistance in Bacteria
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Natasha?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you